Dina L. Masi - 09 Dec 2025 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Chief Financial Officer
Signature
/s/ Dina L Masi
Issuer symbol
INBP
Transactions as of
09 Dec 2025
Net transactions value
$0
Form type
4
Filing time
10 Dec 2025, 17:09:03 UTC
Previous filing
22 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Masi Dina Chief Financial Officer 14 LEXINGTON WAY, LONG VALLEY /s/ Dina L Masi 10 Dec 2025 0001345281

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (Right to Buy) Award $0 +140,000 $0.000000 140,000 09 Dec 2025 Common Stock 140,000 $0.3100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026.